Here is a list of SGLT2 inhibitors, their FDA-approved usage / indications, and the side effects that we are currently investigating:
Invokana / Farxiga / Jardiance / Invokamet / Xigduo / Glyxambi / Synjardy/ Qtern / Steglatro / Steglujan / Segluromet
Prescribed/Used for:
Treatment of type 2 diabetes mellitus (improve glycemic control)
-Invokana (canagliflozin)
-Farxiga (dapagliflozin)
-Jardiance (empagliflozin)
-Invokamet (when treatment with both canagliflozin and metformin is appropriate)
-Xigduo XR (when treatment with both dapagliflozin and metformin is appropriate)
-Glyxambi (when treatment with both empagliflozin and linagliptin is appropriate)
-Synjardy (when treatment with both empagliflozin and metformin is appropriate)
-Qtern (when treatment with both dapagliflozin and saxagliptin is appropriate)
-Steglatro (ertugliflozin)
-Steglujan (when treatment with both ertugliflozin and sitagliptin is appropriate)
-Segluromet (when treatment with both ertugliflozin and metformin hydrochloride is appropriate)
Side Effects We Are Investigating:
-Leg Amputation
-Foot Amputation
-Toe(s) Amputation
– Fournier’s Gangrene (Necrotizing Fasciitis of the Perineum)
Recent articles by attorney Tom Lamb on the Drug Injury Law web site:
- Lower Limb Amputations From All SGLT2 Inhibitors, or Just Invokana?
- Farxiga And Jardiance Have Two-Time Increased Risk For Amputations
- Amputations Are Diabetes Drugs Side Effects For SGLT2 Inhibitors Class
- Lower Limbs Amputations Are SGLT-2 Inhibitors Drug-Class Side Effects
- Fournier’s Gangrene: Side Effect For Invokana, Farxiga, And Jardiance
Go to Drug Injury or Death Case Evaluation for SGLT2 inhibitors diabetes drugs
Go to Drug Injury Law for more information